Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

RSS icon

FDA shares update on heart devices linked to multiple recalls and patient deaths

The devices, designed to provide temporary support to a patient's left ventricle, have been associated with a long list of issues in recent months. 

artificial intelligence healthcare industry digest

ChatGPT’s ‘hallucinations’ make it difficult to trust for advice on cancer care

ChatGPT often gives confusing, conflicting answers about cancer treatments, according to new research out of Brigham and Women's Hospital.

Doctor patient with masks

Should masks still be required at hospitals? Physicians push for a nuanced approach in face of uncertainty

A team of physicians examined the question of continued masking, urging healthcare leaders to work together in a new commentary in Annals of Internal Medicine.

Beloved cardiologist Albert Waldo remembered for his lasting impact on electrophysiology

Waldo was a founding member of the North American Society of Pacing and Electrophysiology, which is now known as the Heart Rhythm Society, and was revered for his helpfulness and kindness.

Recor Medical's Paradise Ultrasound Renal Denervation System

FDA panel votes in favor of Recor Medical renal denervation system

A few members of the panel did question the device's efficacy and long-term durability. The FDA will now use these findings to make its final decision related to the system's approval. 

Thumbnail

Interventional cardiologists call out ABIM for ‘unfair and unjustified’ certification policies

“This situation unacceptably exacerbates the interventional cardiology workforce shortage and threatens to directly impact the care of patients," SCAI wrote in a new statement. 

semaglutide wegovy Novo Nordisk major adverse cardiovascular events

Weight loss drug semaglutide reduces risk of adverse cardiovascular events by 20% among overweight, obese patients

Weekly subcutaneous treatments of semaglutide, originally developed to treat diabetes, are sold and marketed under the brand name Wegovy.

Thumbnail

Expanding Medicaid linked to better care for heart patients

New research, based on data from approximately 143 million patients, focused on prescriptions for heart failure, atrial fibrillation and other significant cardiac conditions. 

Displaying 137 - 144 of 654

Around the web

Cardiovascular Business
Cath lab techs and nurses see new normal with post-COVID pay

In the post-COVID era, wages for permanent RNs are rising, and wages for travelers are decreasing. A new report tracked these trends and more. 

Cardiovascular Business
Merit Medical to purchase Cook Medical’s lead management portfolio for $210M

Two medical device companies have announced a transaction that could shake up the U.S. electrophysiology market. 

Cardiovascular Business
Abiomed, Biosense Webster, Cerenovus now all known as Johnson & Johnson MedTech

These companies were already part of the Johnson & Johnson family, but they had still retained their previous brand names. Now, each one is officially going by Johnson & Johnson MedTech. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup